SDEV
Stablecoin Development Corp
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
0
filed ties
13F top-10 QoQ
Top fund weight
Stablecoin Development Corp
Expected move
InputsNext report
Last report
Largest filed tie
0
filed ties
13F top-10 QoQ
Top fund weight
0.00%
SDEV weight · VTI
No other changes.
No other changes.
No peers for Stablecoin Development Corp yet.
No peers for Stablecoin Development Corp yet.
Annual filing, covered
10-K parsed · Mar 19 '26
Supply-chain ties, covered
None disclosed
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Annual filing, covered
10-K parsed · Mar 19 '26
Supply-chain ties, covered
None disclosed
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
No thesis.
Stablecoin Development Corp
0.96
−0.12 · −10.69%
post 0.98 +1.48%
NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris, rosacea and eczema, anti-aging, SPF, hyperhidrosis, excessive hair, and acne under the DERMAdoctor brand. It sells its products through retailers, digital beauty channels, and distributors, as well as online. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.
NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris, rosacea and eczema, anti-aging, SPF, hyperhidrosis, excessive hair, and acne under the DERMAdoctor brand. It sells its products through retailers, digital beauty channels, and distributors, as well as online. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.
Tall tick = annual report · Source: EDGAR
Expected move
No implied move.
−7.38%
shares held · 10 largest managers
| Manager | Value | % base | |
|---|---|---|---|
| BlackRockindex-like | $445,930 | 28.78% | +0.32% |
| Vanguardindex-like | $343,337 | 22.16% | +20.15% |
| Geodeindex-like | $295,725 | 19.09% | −3.03% |
| Vanguard Fiduciary Trustindex-like | $138,432 | 8.93% | +0.81% |
| State Streetindex-like | $123,012 | 7.94% | 0.00% |
| Manager | Value | % base | |
|---|---|---|---|
| BlackRockindex-like | $445,930 | 28.78% | +0.32% |
| Vanguardindex-like | $343,337 | 22.16% | +20.15% |
| Geodeindex-like | $295,725 | 19.09% | −3.03% |
| Vanguard Fiduciary Trustindex-like | $138,432 | 8.93% | +0.81% |
| State Streetindex-like | $123,012 | 7.94% | 0.00% |